Health Trials

Refractory Immune-mediated Necrotizing Myopathy

1

Review clinical trials related to Refractory Immune-mediated Necrotizing Myopathy. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

A Phase I/II Study of Eque-cel in Subjects Withimmune-mediated Necrotizing Myopathy

This is an open-label, single-arm Phase I/II clinical study to evaluate the efficacy and safety of Eque-cel Injection in patients with refractory immune-mediated necrotizing myopathy.

Participants needed: 27
Trial details
Phase: Phase 1, Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Nanjing IASO Biotechnology Co., Ltd.Updated: Aug 7, 2026Locations: 4
Eligibility criteria

1. At the time of signing the informed consent form, the age is ≥ 18 years old. [+6]

1. Having end-stage myositis with involvement of terminal organs may pose additi... [+20]

Read more